Literature DB >> 6110155

Potent beta-adrenergic antagonist possessing chemically reactive group.

J Pitha, J Zjawiony, N Nasrin, R J Lefkowitz, M G Caron.   

Abstract

Mesh:

Substances:

Year:  1980        PMID: 6110155     DOI: 10.1016/0024-3205(80)90447-6

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


× No keyword cloud information.
  7 in total

1.  Regeneration of beta-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist.

Authors:  J Pitha; B A Hughes; J W Kusiak; E M Dax; S P Baker
Journal:  Proc Natl Acad Sci U S A       Date:  1982-07       Impact factor: 11.205

2.  TRIFUNCTIONAL LIGANDS: A RADIOIODINATED HIGH AFFINITY ACYLATING ANTAGONIST FOR THE A1 ADENOSINE RECEPTOR.

Authors:  Kenneth A Jacobson; Mark E Olah; Gary L Stiles
Journal:  Pharmacol Commun       Date:  1992

3.  Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response.

Authors:  J M May; P W Abel; K P Minneman
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-12       Impact factor: 3.000

4.  The beta-adrenergic receptor: rapid purification and covalent labeling by photoaffinity crosslinking.

Authors:  R G Shorr; S L Heald; P W Jeffs; T N Lavin; M W Strohsacker; R J Lefkowitz; M G Caron
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

5.  Irreversible blockade of beta-adrenergic receptors with a bromoacetyl derivative of pindolol.

Authors:  V Homburger; H Gozlan; R Bouhelal; M Lucas; J Bockaert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-01       Impact factor: 3.000

6.  High affinity acylating antagonists for the A1 adenosine receptor: identification of binding subunit.

Authors:  G L Stiles; K A Jacobson
Journal:  Mol Pharmacol       Date:  1988-12       Impact factor: 4.436

7.  Association of turkey erythrocyte beta-adrenoceptors with a specific lipid component.

Authors:  A Bar-Sinai; Y Aldouby; M Chorev; A Levitzki
Journal:  EMBO J       Date:  1986-06       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.